Yesterday’s approval of a new treatment option for people with #Alzheimer’s disease is incredibly exciting. It also means more accessible, accurate diagnostics are more important than ever. Newly appointed Danaher Executive Vice President for Diagnostics Julie Sawyer Montgomery explains the need for a vast, coordinated effort in the multifaceted fight against Alzheimer’s: https://lnkd.in/ev38CZ3c #speedoflife
Danaher Corporation
Medical Equipment Manufacturing
Washington, District of Columbia 343,722 followers
About us
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. We partner with customers across the globe to help them solve their most complex challenges, architecting solutions that bring the power of science to life. Our global teams are pioneering what’s next across Life Sciences, Diagnostics, Biotechnology and beyond. For more information, visit www.danaher.com.
- Website
-
http://www.danaher.com
External link for Danaher Corporation
- Industry
- Medical Equipment Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Washington, District of Columbia
- Type
- Public Company
- Specialties
- Life Sciences, Diagnostics, and Biotechnology
Locations
-
Primary
Get directions
2200 Pennsylvania Ave NW
800 W
Washington, District of Columbia 20037, US
Employees at Danaher Corporation
Updates
-
High-quality #diagnostics are a cornerstone of our healthcare systems, yet they receive fewer investments and face a more challenging reimbursement environment than new therapeutics. https://bit.ly/3RPqMMk At the Danaher Summit, industry leaders discussed why our value system around diagnostics needs to change and how new standards can ultimately benefit patients. #speedoflife
-
-
Huge congratulations are in order! Well done, Cepheid team 💙 https://bit.ly/3VLrUSd #bestteamwins #speedoflife
Breaking News! Cepheid receives FDA authorization for the first-ever CLIA waived hepatitis C RNA test in the U.S. The Xpert® HCV test enables detection of HCV and facilitates timely linkage to care within a single clinic visit. #MOREtrust, #TheWorldCantWait, #MOREimpact, #HepC, #HepatitisC Read all about it: https://lnkd.in/eSBmXt_R Learn more about Xpert HCV at Cepheid.com/hcv
-
-
Who improves human health around the world by accelerating the power of science and technology? Find out how Danaher helps scientists and innovators discover, develop and deliver ideas that improve human health. Discover Danaher: https://lnkd.in/e6Aepd9u
-
Getting new #diagnostics into the clinic is complex, from setting up reimbursements to getting adopted by health systems and gaining the trust of providers. It's also essential to improving patient outcomes. https://bit.ly/3XBFPNg At the Danaher Summit, thought leaders across all these systems described the challenges of integrating new, beneficial diagnostics into clinical practice.
-
-
We're pleased to share that Julie Sawyer Montgomery has been appointed Executive Vice President for our #diagnostics businesses. https://bit.ly/3VpI2Zy "During her tenure, Julie has shown tremendous commitment to supporting our customers, building winning teams, driving innovation and leading with the Danaher Business System. "I look forward to seeing Julie apply her skills and experiences to help ensure the ongoing success of our entire Diagnostics franchise, as we work to improve outcomes for patients with faster, more accurate diagnoses," said Danaher President & CEO Rainer Blair.
-
-
Digital pathology is poised to be a major revolution in how quickly and accurately we diagnose disease. Rob Monroe, MD, PhD, opines on how coupling digital pathology with #AI will transform #diagnostics as we know it: https://bit.ly/3Vugke7
-
-
From augmenting the provider-patient dynamic to speeding up data analysis, #AI is poised to transform #diagnostics. Experts weighed in on what it will take to bring diagnostics into the data-driven future at our annual Summit: https://bit.ly/3VifzVn
-
-
For six months after she sustained a #traumaticbraininjury, Louise was told she had a mild concussion. She is one of nearly 56 million mild #TBI patients worldwide who could benefit from objective, blood-based diagnostic tests that identify mild TBI earlier and more precisely. Her story and our collaboration to improve neurological diagnosis here: https://bit.ly/3Vvlyqe
Affiliated pages
Similar pages
Browse jobs
Stock
DHR
NYSE
20 minutes delay
$240.00
-0.41 (-0.171%)
- Open
- 240.91
- Low
- 240
- High
- 243.06
Data from Refinitiv
See more info on